A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
Clinical trial NCT06693284 · RECRUITING
Trial details
- NCT number
- NCT06693284
- Sponsor
- University of Minnesota
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-20
- Primary completion
- 2027-01-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.